Uncertainty in the stock market makes it difficult to make investment decisions. When investors sell off stocks, everyone follows without giving it much thought and you’re left trying to figure out which path you should…
-
-
The Yield Curve The RRG above shows the rotations of the various maturities on the US-Yield Curve. What we see at the moment is that the shorter maturities like BIL, SHY, and IEI are in…
-
When running my StockCharts Technical Rank (SCTR) scan on Thursday, I was a little surprised to find that 75 exchange-traded funds (ETFs) and large-cap stocks made the cut, especially after Wednesday’s selloff. It was a…
-
HIGHLIGHTS BBM trend now extends over 15km, from Awalé’s 100%-owned Fremen target in the south to the Boba and Fett targets in the north. Boba and Fett have been defined along strike from BBM, highlighting…
-
AgTech Company highlights recent 100% purchase of Hemp Carbon Standard platform to advance industrial hemp carbon credits global market opportunity Hempalta Corp. (TSXV: HEMP) (‘Hempalta’ or the ‘Company’) has released its financial results for the…
-
Investing
Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt
(TheNewswire) December 19th, 2024 TheNewswire – Vancouver, B.C. Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD) (OTCQB: OPWEF) (the ‘Company’ or ‘Opawica’) a Canadian mineral exploration company focused on precious and base metal projects, is pleased…
-
Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that the Company is not aware of any undisclosed material information that might be contributing to the recent decline in the…
-
Investing
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral drug, CardiolRx, which is entering…
-
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com
-
Westgold Resources (ASX:WGX,TSX:WGX,OTCQX:WGXRF) has completed a scoping study that evaluates an expansion of its Fortnum gold operation in Western Australia, the company said on Tuesday (December 17). The study forms part of the company’s portfolio…